DZ1637A1 - N'n'-diacetyl cystine organic salts. - Google Patents

N'n'-diacetyl cystine organic salts.

Info

Publication number: DZ1637A1
Authority: DZ; Algeria
Prior art keywords: organic salts; diacetyl cystine; cystine; diacetyl; salts
Prior art date: 1991-11-29

Inventor

Carl Magnus Andersson

Hakan Bergstrand

Edib Jakupovic

Bo-Goran Josefsson

Magnus Lindvall

Bengt Sarnstrand

Eric Teneberg

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-29

Filing date

1992-11-25

Publication date

2002-02-17

1992-11-25Application filed by Astra AbfiledCriticalAstra Ab

2002-02-17Application grantedgrantedCritical

2002-02-17Publication of DZ1637A1publicationCriticalpatent/DZ1637A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
- C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DZ920148A1991-11-291992-11-25 N'n'-diacetyl cystine organic salts.DZ1637A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9103572ASE9103572D0 (en)	1991-11-29	1991-11-29	ORGANIC SALTS OF N, N'-DIACETYL CYSTINE

Publications (1)

Publication Number	Publication Date
DZ1637A1true DZ1637A1 (en)	2002-02-17

Family

ID=20384494

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ920148ADZ1637A1 (en)	1991-11-29	1992-11-25	N'n'-diacetyl cystine organic salts.

Country Status (38)

Country	Link
US (5)	US5385904A (en)
EP (1)	EP0621862B1 (en)
JP (1)	JP3302018B2 (en)
KR (1)	KR100256185B1 (en)
CN (1)	CN1039586C (en)
AP (1)	AP350A (en)
AT (1)	ATE141913T1 (en)
AU (1)	AU657827B2 (en)
CA (1)	CA2123516A1 (en)
CZ (1)	CZ282085B6 (en)
DE (1)	DE69213256T2 (en)
DK (1)	DK0621862T3 (en)
DZ (1)	DZ1637A1 (en)
EE (1)	EE03025B1 (en)
ES (1)	ES2090713T3 (en)
FI (1)	FI942504L (en)
GR (1)	GR3021546T3 (en)
HK (1)	HK62297A (en)
HR (1)	HRP921322B1 (en)
HU (1)	HU215390B (en)
IL (1)	IL103778A (en)
IS (1)	IS1645B (en)
LV (1)	LV11949B (en)
MA (1)	MA22716A1 (en)
MX (1)	MX9206851A (en)
MY (1)	MY110523A (en)
NO (1)	NO301325B1 (en)
NZ (1)	NZ245077A (en)
PL (2)	PL171336B1 (en)
RU (1)	RU2135468C1 (en)
SE (1)	SE9103572D0 (en)
SG (1)	SG73962A1 (en)
SI (1)	SI9200351A (en)
SK (1)	SK281697B6 (en)
TN (1)	TNSN92108A1 (en)
WO (1)	WO1993011104A1 (en)
YU (1)	YU48594B (en)
ZA (1)	ZA928739B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3865463A (en)*	1973-11-12	1975-02-11	Busch & Co Inc Ag	Electrical adapter plug
ATE144142T1 (en)*	1991-01-10	1996-11-15	Transcend Therapeutics Inc	USE OF THIAZOLIDINE-4-CARBOXYLATE DERIVATIVES FOR THE TREATMENT OF LUNG DISEASES
US5747459A (en)*	1991-02-04	1998-05-05	Nestec, Ltd.	Method for insuring adequate intracellular glutathione in tissue
US5430045A (en)*	1992-04-23	1995-07-04	Free Radical Sciences, Inc.	Method of reducing or preventing bone marrow hypoplasia
US5447712A (en)*	1993-12-09	1995-09-05	Free Radical Sciences	Method of reducing cyclophosphamide induced hemorrhagic cystitis
SE9500897D0 (en)*	1995-03-14	1995-03-14	Astra Ab	The pharmacological use of certain cysteine derivatives
SE9602262D0 (en)*	1996-06-06	1996-06-06	Astra Ab	New use of cystine derivatives
US6017959A (en)*	1996-06-18	2000-01-25	Astra Aktiebolag	Forms of organic salts of N,N'-diacetylcystine
AR007398A1 (en)*	1996-06-18	1999-10-27	Astrazeneca Ab	PROCESS TO PREPARE INORGANIC SALTS OF N-N'-DIACETILCISTINA
SE9602416D0 (en)*	1996-06-18	1996-06-18	Astra Ab	New forms of an organic salt of N'N-diacetylcystine
CN1059907C (en)*	1997-05-23	2000-12-27	中国石油化工集团公司巴陵石化岳阳石油化工总厂	Selective hydrogenation method for conjugated dienes polymer
US6197749B1 (en)*	1997-10-29	2001-03-06	Ajinomoto Co., Inc.	Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
US20030203006A1 (en)*	1997-10-29	2003-10-30	Ajinomoto Co. Inc.	Immunomodulator
SE9800932D0 (en)	1998-03-20	1998-03-20	Astra Ab	New compunds
EP1004302A3 (en)*	1998-10-29	2003-06-04	Ajinomoto Co., Inc.	Immunomodulator
SE9900438D0 (en)*	1999-02-10	1999-02-10	Astra Ab	The pharmacological use of certian cystine derivatives
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
NO20003591L (en)*	2000-07-13	2002-01-14	Thia Medica As	Fatty acid analogues for the treatment of cancer
SE518784C2 (en)*	2000-12-27	2002-11-19	Nactilus Ab	"N-Acetyl-L-Cysteine with Compositions for the Treatment of Neoplasms"
KR20040021589A (en)*	2001-03-13	2004-03-10	아지노모토 가부시키가이샤	Cosmetics or external preparations for skin
RU2317299C2 (en)*	2001-08-10	2008-02-20	Кабусики Кайся Хаясибара Сеибуцу Кагаку	Associate containing trehalose and calcium chloride as crystalline monohydrate or anhydrous crystal
ES2425392T3 (en)	2002-03-20	2013-10-15	Mannkind Corporation	Cartridge for an inhalation device
JP4794433B2 (en)*	2003-03-11	2011-10-19	ファルマシアコーポレーション	S- [2-[(1-Iminoethyl) amino] ethyl] -2-methyl-L-cysteine maleate hydrochloride crystalline salt
JP5078014B2 (en)	2004-08-20	2012-11-21	マンカインドコーポレイション	Catalytic reaction of diketopiperazine synthesis.
PL2322180T3 (en)	2004-08-23	2015-10-30	Mannkind Corp	Diketopiperazine salts for drug delivery
CN104324366B (en)	2005-09-14	2016-10-05	曼金德公司	Method for preparation of drug based on improving the active agent affinity to crystalline microparticle surfaces
KR20080096809A (en)	2006-02-22	2008-11-03	맨카인드 코포레이션	Method for Improving Pharmaceutical Properties of Microparticles Containing Diketopiperazine and Active Agents
US8438729B2 (en)*	2006-03-09	2013-05-14	Canon Kabushiki Kaisha	Method of producing liquid discharge head
MY155524A (en)	2008-06-13	2015-10-30	Mannkind Corp	A dry powder inhaler and system for drug delivery
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
KR101628410B1 (en)	2008-06-20	2016-06-08	맨카인드 코포레이션	An interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (en)	2008-08-11	2016-05-11	曼凱公司	Ultra-fast use of insulin
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (en)	2009-03-11	2013-12-16	Mannkind Corp	DEVICE, SYSTEM AND PROCEDURE FOR MEASURING RESISTANCE IN AN INHALATOR
KR20180079458A (en)	2009-06-12	2018-07-10	맨카인드 코포레이션	Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en)	2009-11-03	2015-04-28	Mannkind Corporation	Apparatus and method for simulating inhalation efforts
BR112012033060A2 (en)	2010-06-21	2018-02-27	Mannkind Corp	Dry powder drug release system methods
AU2012236150B2 (en)	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
AU2012328885B2 (en)	2011-10-24	2017-08-31	Mannkind Corporation	Methods and compositions for treating pain
CN102491926B (en)*	2011-12-15	2013-09-25	青岛市药品检验所	Method for preparing and purifying tiopronin disulphide
SG10201605800UA (en)	2012-07-12	2016-09-29	Mannkind Corp	Dry powder drug delivery system and methods
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
AU2014228415B2 (en)	2013-03-15	2018-08-09	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (en)	2013-07-18	2022-11-09	맨카인드 코포레이션	Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en)	2013-08-05	2015-02-12	Mannkind Corporation	Insufflation apparatus and methods
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
WO2021219376A1 (en)*	2020-04-28	2021-11-04	Unilever Ip Holdings B.V.	Personal care compositions with enhanced solubility actives
EP4216939A4 (en)*	2020-09-28	2024-10-23	Georgia Tech Research Corporation	USE OF CYSTIN AND ITS DERIVATIVES AS ANTITHROMBOTIC AND THROMBOLYTIC AGENTS

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB592631A (en)*	1945-04-04	1947-09-24	Du Pont	Cysteine and cystine
GB954268A (en)	1962-02-26	1964-04-02	Mead Johnson & Co	Decongestant compositions comprising n-acylated sulphydryl compounds
FR8205M (en)*	1968-12-20	1970-09-14
US3647834A (en)*	1969-08-11	1972-03-07	Mead Johnson & Co	Zinc mercaptide n-acetylcysteine carboxylate salts
US3878305A (en)*	1972-05-25	1975-04-15	Procter & Gamble	Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
US3952115A (en)*	1975-04-02	1976-04-20	The Procter & Gamble Company	Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
US4141734A (en)*	1975-09-11	1979-02-27	Ciba-Geiby Ag	Photographic developing process
US4093739A (en)*	1977-06-15	1978-06-06	Mead Johnson & Company	Mercaptoacylamidobenzoyl glycine and mucolytic process
JPS6011888B2 (en)*	1978-10-11	1985-03-28	参天製薬株式会社	Rheumatic disease treatment drug
JPS56155298A (en)*	1980-05-02	1981-12-01	Tanabe Seiyaku Co	Shampoo composition
GB2097256B (en)*	1981-04-02	1985-05-30	Morelle Jean V	Compositions containing n-butyryl alphaaminoacids
FR2503151A1 (en)*	1981-04-02	1982-10-08	Morelle Jean	Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use
JPS58164566A (en)*	1982-03-09	1983-09-29	Kenji Okawa	Production of cystine
US4724239A (en)*	1985-09-16	1988-02-09	Morgan Lee R	Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4827016A (en)*	1985-09-16	1989-05-02	Morgan Lee R	Method and compounds for reducing dermal inflammations
US4708965A (en)	1985-09-16	1987-11-24	Morgan Lee R	Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPH0660157B2 (en)*	1985-11-20	1994-08-10	三井東圧化学株式会社	Method for producing cystine from cysteine
JPS62195356A (en)*	1986-02-20	1987-08-28	Seiwa Kasei:Kk	Cystine derivative and salt thereof
AT402931B (en)*	1986-11-07	1997-09-25	Pharmacia Gmbh	METHOD FOR PRODUCING NEW CYSTINE COMPOUNDS AND USE THEREOF
SE8704542D0 (en)*	1987-11-19	1987-11-19	Draco Ab	NEW DERIVATIVES OF CYSTEINE
IL98310A (en)*	1990-06-08	1996-08-04	Astra Ab	Pharmaceutical compositions comprising cystine derivatives
TW221376B (en)*	1990-06-28	1994-03-01	Astra Ab
GB9111885D0 (en)*	1991-06-03	1991-07-24	Erba Carlo Spa	Nerve growth factor for use in the prevention and treatment of viral infections

1991
- 1991-11-29SESE9103572Apatent/SE9103572D0/enunknown
1992
- 1992-11-10NZNZ245077Apatent/NZ245077A/enunknown
- 1992-11-12ZAZA928739Apatent/ZA928739B/enunknown
- 1992-11-17ILIL10377892Apatent/IL103778A/ennot_activeIP Right Cessation
- 1992-11-18YUYU99092Apatent/YU48594B/enunknown
- 1992-11-20APAPAP/P/1992/000448Apatent/AP350A/enactive
- 1992-11-23HRHR9103572-5Apatent/HRP921322B1/ennot_activeIP Right Cessation
- 1992-11-23TNTNTNSN92108Apatent/TNSN92108A1/enunknown
- 1992-11-24MAMA23006Apatent/MA22716A1/enunknown
- 1992-11-24ISIS3949Apatent/IS1645B/enunknown
- 1992-11-25WOPCT/SE1992/000807patent/WO1993011104A1/enactiveIP Right Grant
- 1992-11-25SKSK632-94Apatent/SK281697B6/enunknown
- 1992-11-25SGSG1996004497Apatent/SG73962A1/enunknown
- 1992-11-25FIFI942504Apatent/FI942504L/enunknown
- 1992-11-25PLPL92314567Apatent/PL171336B1/enunknown
- 1992-11-25DEDE69213256Tpatent/DE69213256T2/ennot_activeExpired - Fee Related
- 1992-11-25DZDZ920148Apatent/DZ1637A1/enactive
- 1992-11-25ESES92924975Tpatent/ES2090713T3/ennot_activeExpired - Lifetime
- 1992-11-25JPJP51003993Apatent/JP3302018B2/ennot_activeExpired - Fee Related
- 1992-11-25MYMYPI92002155Apatent/MY110523A/enunknown
- 1992-11-25ATAT92924975Tpatent/ATE141913T1/ennot_activeIP Right Cessation
- 1992-11-25KRKR1019940701815Apatent/KR100256185B1/ennot_activeExpired - Fee Related
- 1992-11-25DKDK92924975.3Tpatent/DK0621862T3/enactive
- 1992-11-25HUHU9401473Apatent/HU215390B/ennot_activeIP Right Cessation
- 1992-11-25EPEP92924975Apatent/EP0621862B1/ennot_activeExpired - Lifetime
- 1992-11-25CACA002123516Apatent/CA2123516A1/ennot_activeAbandoned
- 1992-11-25AUAU30996/92Apatent/AU657827B2/ennot_activeCeased
- 1992-11-25PLPL92303924Apatent/PL170787B1/enunknown
- 1992-11-25RURU94027569/04Apatent/RU2135468C1/ennot_activeIP Right Cessation
- 1992-11-25USUS07/981,373patent/US5385904A/ennot_activeExpired - Lifetime
- 1992-11-25CZCZ941297Apatent/CZ282085B6/ennot_activeIP Right Cessation
- 1992-11-27MXMX9206851Apatent/MX9206851A/ennot_activeIP Right Cessation
- 1992-11-28CNCN92113666Apatent/CN1039586C/ennot_activeExpired - Fee Related
- 1992-11-30SISI19929200351Apatent/SI9200351A/enunknown
1994
- 1994-05-26NONO941968Apatent/NO301325B1/ennot_activeIP Right Cessation
- 1994-11-08USUS08/335,941patent/US5693858A/ennot_activeExpired - Fee Related
- 1994-11-17EEEE9400378Apatent/EE03025B1/ennot_activeIP Right Cessation
1995
- 1995-06-07USUS08/477,387patent/US5804582A/ennot_activeExpired - Fee Related
- 1995-06-07USUS08/476,218patent/US5650538A/ennot_activeExpired - Lifetime
- 1995-06-07USUS08/484,143patent/US5824681A/ennot_activeExpired - Fee Related
1996
- 1996-11-06GRGR960402920Tpatent/GR3021546T3/enunknown
1997
- 1997-05-08HKHK62297Apatent/HK62297A/ennot_activeIP Right Cessation
- 1997-08-28LVLVP-97-158Apatent/LV11949B/enunknown

Also Published As

Publication number	Publication date
CZ129794A3 (en)	1995-01-18
PL170787B1 (en)	1997-01-31
HRP921322B1 (en)	1998-12-31
FI942504A0 (en)	1994-05-27
US5824681A (en)	1998-10-20
YU99092A (en)	1995-12-04
AP9200448A0 (en)	1993-01-31
ATE141913T1 (en)	1996-09-15
PL171336B1 (en)	1997-04-30
US5650538A (en)	1997-07-22
IL103778A0 (en)	1993-04-04
SK63294A3 (en)	1995-02-08
NZ245077A (en)	1995-04-27
GR3021546T3 (en)	1997-02-28
CA2123516A1 (en)	1993-06-10
TNSN92108A1 (en)	1993-06-08
HRP921322A2 (en)	1996-10-31
LV11949B (en)	1998-07-20
EP0621862A1 (en)	1994-11-02
JPH07501539A (en)	1995-02-16
AU657827B2 (en)	1995-03-23
NO941968L (en)	1994-05-26
NO941968D0 (en)	1994-05-26
CN1039586C (en)	1998-08-26
HK62297A (en)	1997-05-16
ZA928739B (en)	1993-06-09
HU9401473D0 (en)	1994-08-29
RU2135468C1 (en)	1999-08-27
FI942504A7 (en)	1994-05-27
DE69213256D1 (en)	1996-10-02
WO1993011104A1 (en)	1993-06-10
EE03025B1 (en)	1997-08-15
EP0621862B1 (en)	1996-08-28
IS3949A (en)	1993-05-30
CN1073683A (en)	1993-06-30
KR100256185B1 (en)	2000-05-15
SI9200351A (en)	1993-06-30
IL103778A (en)	1997-08-14
US5385904A (en)	1995-01-31
JP3302018B2 (en)	2002-07-15
SE9103572D0 (en)	1991-11-29
MX9206851A (en)	1993-05-01
HU215390B (en)	1998-12-28
AU3099692A (en)	1993-06-28
ES2090713T3 (en)	1996-10-16
HUT70851A (en)	1995-11-28
YU48594B (en)	1998-12-23
SK281697B6 (en)	2001-06-11
US5804582A (en)	1998-09-08
LV11949A (en)	1998-01-20
SG73962A1 (en)	2000-07-18
AP350A (en)	1994-08-09
DK0621862T3 (en)	1996-09-16
FI942504L (en)	1994-05-27
IS1645B (en)	1997-03-25
MA22716A1 (en)	1993-07-01
CZ282085B6 (en)	1997-05-14
MY110523A (en)	1998-07-31
US5693858A (en)	1997-12-02
NO301325B1 (en)	1997-10-13
DE69213256T2 (en)	1997-01-23

Publication	Publication Date	Title
DZ1637A1 (en)	2002-02-17	N'n'-diacetyl cystine organic salts.
FI912924L (en)	1991-12-19	LADDADE ORGANIC POLYMER MIKROPAERLOR I PAPERSFRAMSTAELLNINGSPROCESS.
FI923314L (en)	1993-01-26	SUBSTITUERADE CYCLOPROPYLAMINO-1,3,5-TRIAZINER
MX9204547A (en)	1993-03-01	NERISTATINE 1.
FR2681927B1 (en)	1995-11-03	ADVANCED ROTATING MECHANISM.
NO921851L (en)	1992-11-24	"Umbilical" -FRIGJOERINGSMEKANISME
FR2713641B1 (en)	1997-04-11	Epi-epibatidine derivatives.
DE69010184D1 (en)	1994-07-28	Naphthotriazolium salts.
DK0517660T3 (en)	1997-10-27	Benzo-1,2,3-thiadiazole-derivatives.
FR2699716B1 (en)	1995-02-10	Labeling sleeve.
FI921456L (en)	1992-10-06	SUBSTITUERADE 2',3'-DIDESOXI-5-TRIFLUORMETHYLURIDINER, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL
FI923009A7 (en)	1993-01-02	Concentrated water-soluble organic lanthanide salts
FR2678080B1 (en)	1994-05-20	CLOCK ARTICLE.
FI912750A0 (en)	1991-06-07	EL DOSA.
FR2667688B1 (en)	1994-04-29	ULTRA-FAST ACQUISITION CIRCUIT.
NO922732D0 (en)	1992-07-10	3,4-DEHYDROPIPERIDINDERIVATER
FR2677788B1 (en)	1995-07-13	BILLBOARD.
FR2660805B1 (en)	1992-07-24	WATERPROOF ILLUMINATION SOCKET.
FR2680032B1 (en)	1994-01-21	LIGHT ANIMATION PROCESS.
FI911849A0 (en)	1991-04-17	BASTU UGN 5.
SE9002275D0 (en)	1990-06-28	NOVEL 3,3'-DITHIOBIS (PROPIONIC ACIDS)
IT9029546V0 (en)	1990-06-08	SOCIETY GAME'.
BR9105070A (en)	1993-05-25	INTELLIGENT FORMULA 1 GAME
FR2659027B1 (en)	1993-06-11	CASTLE OF CHINESE SHADOWS.
ITAV910001A0 (en)	1991-04-11	"MARIA" PATENT.

Movatterモバイル変換